We are calling registered physicians, pharmacists, and nurses in the Philippines to answer the following survey to help us understand medication safety reporting habits and improve methods for medication safety monitoring, as well as to evaluate the Philippine FDA e-Reporting to determine its usability:
Understanding Underreporting of Adverse Drug Reactions in the Philippines:
FDA e-Reporting System Usability Survey:
Survey links will be available until 26 March 2022; 11:59 PHT.
Together let’s improve the practice of pharmacovigilance in our country and together we’ll be #savinglives